Challenges of Clinical Decision Support System Development by Houdová, Lucie et al.
25TH INTERNATIONAL CONFERENCE ON INFORMATION SYSTEMS DEVELOPMENT (ISD2016 POLAND) 
455 
 
Challenges of Clinical Decision Support System Development  
Lucie Houdová houdina@ntis.zcu.cz 
NTIS - New Technologies for the Information Society, University of West Bohemia  
Plzeň, Czech Republic 
Miloš Fetter fetter@kky.zcu.cz 
Department of Cybernetics, Faculty of Applied Sciences, University of West Bohemia  
Plzeň, Czech Republic 
Oldřich Balák obal@civ.zcu.cz 
NTIS - New Technologies for the Information Society, University of West Bohemia  
Plzeň, Czech Republic 
Jiří Fatka fatkaj@ntis.zcu.cz 
NTIS - New Technologies for the Information Society, University of West Bohemia  
Plzeň, Czech Republic 
Ondřej Průcha ondrous@civ.zcu.cz 
Centre for Information Technology, University of West Bohemia 
Plzeň, Czech Republic 
Pavel Jindra jindra@fnplzen.cz 
Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague  
Plzeň, Czech Republic 
Daniel Georgiev georgiev@ntis.zcu.cz 
NTIS - New Technologies for the Information Society, University of West Bohemia  
Plzeň, Czech Republic 
 
Abstract 
One of the high-growing areas in medicine is research and development of advanced IT 
technologies for clinical decision support. Clinical decision support system (CDSS) must be 
able to store the necessary clinical data and also to analyze this data, and process and interpret 
the results for a specialist. This article is focused on interdisciplinary research and development 
challenges in developing a complex information system for searching and selecting a suitable 
donor for bone marrow transplantation using an advanced DNA-based donor search model. The 
particular challenges are summarized and the approaches to tackle them are described. 
Keywords: CDSS development, decision support, biocybernetics methods, DNA search, bone 
marrow transplant. 
1. Introduction  
Clinical decision support systems (CDSS) are computer systems designed for clinician decision 
making about individual patients [1]. More precisely, these systems can be described as adapted 
decision support systems (DSS) defined as extensible systems with intrinsic capability to 
support ad hoc data analysis and reduction, as well as decision modeling activities [5] 
specifically designed for physicians to make or improve clinical decisions. CDSS are highly 
specialized for the various processes of healthcare. The development is always very complex 
and full of challenges of a different kind due to the necessary interdisciplinary holistic approach 
characterized by considerable demands on knowledge both in medicine and in the field of IT. 
Therefore, we present the challenges of CDSS development in one particular case, namely in 
research and development of advanced IT technologies for support of the bone marrow donor 





interdisciplinarity, but also in terms of DSS classification (according to [9]). It is basically a 
knowledge-driven DSS (could simulate human thinking in a particular domain) but it has 
elements of model-driven (help to analyze and choose between different options) and 
communication-driven DSS (focuses on different users collaboration and makes the decision-
making faster and more productive), i.e., can be defined as a hybrid DSS. Some challenges have 
also arisen due to the integration of biocybernetics methods and approaches into the standard 
information system (IS) methodologies and technologies. 
2. Clinical background 
Due to the CDSS development description and its specific challenges, it is appropriate to 
provide at least a basic background of the bone marrow donor search. The presented CDSS is 
primarily based on biomedical knowledge of the issues of human leukocyte antigen (HLA) 
system, of the hematopoietic blood stem cells transplantation process, knowledge in the 
cybernetics area (mostly analytical), and in information technology. Thus, in our case it means 
a cooperation of physicians and technicians in the HLA laboratory performing HLA typing of 
donors and patients, physicians performing a search of potential donors for stem cell 
transplantation, other health care professional staff, and also part of the research team involved 
in analysis and development methods, as well as a group of IT professionals engaged in 
applications implementation, communication interfaces, connection of existing information, 
communication system parts and complete system support.  
The key process before transplantation of bone marrow or peripheral blood stem cells is to find 
the optimal donor for particular patient from a database of potential donors, i.e., to perform a 
"search".  An absolutely essential requirement for successful transplantation is a degree of HLA 
match between the donor and the patient [7]. The fundamental functionality of the CDSS for 
the bone marrow donor registry is to provide a list of potentially suitable donors with a search 
algorithm in the shortest possible time and to facilitate the very choice of a suitable donor as 
fast as possible [10]. 
The issue of match in the HLA system between the patient and the bone marrow donor at the 
highest possible level has become more complicated with the advent of the DNA techniques 
used for HLA typing. Given the proven importance of their use (compared to the previously 
used serological techniques) [4] a need arises to create a new CDSS including models matching 
the current global trend of using the DNA information and the needs of patients for all 
worldwide marrow donors registries.  
When selecting a donor many HLA and many non-HLA factors (e.g., gender, age, 
cytomegalovirus status) are considered. Each person gives a complete genetic program 
observable as phenotype, consisting of 2 haplotypes of HLA genes (one from the father and 
one from the mother), together known as the haplotype pair. The compatibility of the patient-
donor is observed on 5 loci (genes) for each haplotype – HLA-A, B, C, DRB1, and DQB1 locus. 
However, for most donors this knowledge is incomplete. Hence, it is necessary to estimate 
concrete alleles – specific gene variants for the unknown ones. The knowledge of specific 
alleles is conditioned by the level of typing resolution. So, if e.g., the HLA-B locus is typed as 
27s (serological typing) or 27:HMHK (National Marrow Donor Program (NMDP) code) is also 
necessary for donor search to determine the likelihood of specific allele occurrence (e.g., 27:02) 
in the particular case. Simply, if the HLA information is incomplete, it is necessary to estimate 
the unknown alleles (both patient and donor), and determine the probability of the patient-donor 
match (for the entire donors dataset). The desired match level may not be the only level of 10/10 
(all 10 donor’s alleles are identical to the 10 patient alleles), but also other, e.g., 9/10B meaning 
one mismatch on B locus (9 alleles of the donor and the patient are identical). 
The presented system was developed in cooperation with the Czech National Marrow Donors 
Registry (CNMDR), which is currently the largest marrow donor registry in Central and Eastern 
Europe, enabling around 100 unrelated hematopoietic blood stem cells transplants every year. 
The CNMDR operates throughout the Czech Republic through ten contractual donor centres at 
regional and immunological transfusion hematology wards. Work of individual donor centres 




is centrally coordinated by the CNMDR coordination centre, which also provides 
communication with the transplant centres and international registries. The HLA typing is 
carried out in an accredited HLA laboratory [8].  
3. Challenges of CDSS development 
Because an essential factor in the entire donor search process is time, one of the major 
challenges was communication process optimization. The other challenges, which we had to  
face during design and system solutions, were necessary restrictions of each users’ certain 
specific requirements because of the compliance requested by the World Marrow Donor 
Association (WMDA) international accreditation standards and standard operating procedures 
of donors’ registry. Other limitations were caused by personal data exchange in an automated 
national and international communication, by specifics of processing of necessary medical data 
and the knowledge or even the actual negotiation with the physicians or laboratory technicians. 
Others challenges were related to the actual CDSS design, e.g., using biocybernetics methods 
for integration of new donor searching system components or to standard problems solved 
during a DSS development, e.g., the issue of the necessary database or the verification of 
decisions correctness and accuracy. 
It is more complicated when it is not possible to start the development completely anew but 
instead must be accept that there are in the past defined - and partially invalid - data sources (in 
the case of the CNMDR collected from 1992); it is necessary to get familiar with how 
everything procedurally works. It is also required to ensure the least possible interference with 
the current operation and clinical practice, and simultaneously optimize the processes. In our 
case a great emphasis on these issues is put by the CNMDR legal entity in the form of a public 
service company. So, besides the required integration of new donors search methods and related 
both medical and technical challenges, also challenges appeared based on the largest possible 
procedures and applications  preservation while complying with the CNMDR standard 
operating procedures and meeting the requirements of international accreditation organization 
(WMDA). 
In summary, the specifics of the developed system compared to other CDS systems are 1) a 
method for requirement specification – requirements for IS specific components and functions 
are missing. Specifically requirements regarding preservation of part functionality from the 
existing system used in clinical practice, 2) IS functionality is limited not only by national 
standards but also by WMDA standards. Specifically, IS has to have an interface for automated 
international communication, 3) the CDSS is highly distributed, and 4) IS 
knowledge/model/communication-based hybridity, as mentioned above, is not common in 
CDSS.  
The whole CDSS for bone marrow donor search development and challenges associated 
with it are demonstrated in Fig. 1. The diagram shows links for development of subsequent 
activities and obvious CDSS development complexity. It can be seen that the CDSS knowledge 
base was created according to analysis results and gained medical knowledge obtained from 
requirement specification, the model was based on the proposed methodology and knowledge 
about haplotype and phenotype diversity with regards to DNA typing resolution level (NMDP 
codes).  The inference engine operation needs data from the knowledge base and from the 
model.  The challenges connected with single steps of the unified CDSS development are 







Fig. 1. Complexity of CDSS for bone marrow donor search development 
During designing a CDSS there are always the same issues as during a classical DSS 
development but with some health care specifities as well the challenges attributed to the actual 
clinical focus. Hereby, one group of challenges appears commonly in the DSS design and can 
be always considered as critical, particularly for the knowledge-driven DSS development. In 
this case it must be clear what data and knowledge are actually available and what will be 
available in the future for decision support. In general, it is necessary to have all available 
information incorporated into the information and communication systems so that they can 
serve as parts of the system knowledge base. 
3.1 Challenge 1: Requirements specification 
The very first challenge was the requirement for establishing the CDSS itself. A significant 
difference from the standard IS development was the method of requirements specification. As 
stated earlier, there are no requirements for IS specific components and functions. Specifically, 
regarding the resulting activity, global needs and needs for preservation of part functionality 
from the existing system used in clinical practice. Therefore, requirement definition was carried 
out continuously during IS development, repeatedly in several steps, including frequent 
validation of gradually developed components and integration of permanent changes.  
In doing so, rough understanding of IT development techniques was required on the side of 
medical professionals. All during the system analysis and the technical development phases, 
technical, and practical requirements were jointly formulated by medical professionals, and 
medical-IT coordinator. For instance, event-driven process chains (EPC), and entity-
relationship modeling (ERM) techniques were selected for their intuitiveness as well as for their 
flexibility, and past implementations by the research team. Details are described in Section 3.3.  
The general requirement was based on current global needs, e.g., on the possibility of using 
donor/patient DNA information. It meant to create a single CNMDR system capable to 
recommend the most suitable HLA typed donor to the transplant centres (primarily for Czech 
patients) using the known DNA information with a focus on optimizing the time component of 
the search process. Because time – hence the speed of identifying a compatible donor and urgent 




performing of unrelated transplantation – is one of the key factors for optimal transplantation 
results. 
It is necessary to mention that dealing with the general requirements was heavily influenced by 
communication obstacles. The process of final donor selection includes a cooperation of several 
registry components such as donor centres (DCs), national transplant centres (TCs), and the 
coordination centre (CC), which also coordinates the registry activities on international level. 
Each of these components had their own information structures (from paper records via Excel 
spreadsheets to different variants of databases), its own processes and operating methods and 
each produces its own data in its own record form.  
A more detailed requirement specification was based on an initial analysis of efficiency factors 
limited by the CNMDR ICT. The following major limitations were identified: 1) inadequate 
"search" algorithm based solely on serology technique of HLA typing, unsuitable and 
insufficient assessment and screening of donor suitability still based largely on subjective 
physician decisions, 2) absence of any analysis of the registry database (genetic diversity, 
frequency of haplotype, alleles etc.) and as a consequence the absence of  prognostic 
information provided to TCs in terms of probability and speed of finding a compatible donor, 
3) lack of registry processes, donor recruitment and existing typing strategy efficiency analysis, 
absence of an interim analysis and comprehensive statistical analysis of the individual steps of 
the search process – required by accreditation organizations (WMDA key performance 
indicators) and currently performed manually and 4) data records fragmentation, i.e., absence 
of a DCs database, its linkage with the CNMDR database (CC and HLA lab database), 
information and knowledge connection of the individual search process components, absence 
of IT communication among CC, TCs, selected European databases, and worldwide registers 
and related IS security. 
The initial analysis was followed by a deeper analysis carried out in cooperation with particular 
CNMDR components. It can be said that the CNMDR had the whole area of information 
technology grossly inadequate. So, in this particular case it was necessary to focus on three 
main areas: 1) the facilitation of communication between the CNMDR components, 2) the 
facilitation of donor selection for physicians and 3) maintaining the highest security and 
necessary anonymity throughout the search process, implying already mentioned hybridity of 
the IS.  
Herein, it is important to note that the possibility of specific requirement implementation had 
to be analyzed and compared with the prescriptive requirements and restrictions of supervisory 
health organizations. This always has a priority and it is one of the fundamental limitations of 
the CDSS development. 
3.2 Challenge 2: CDSS development management 
One of the most crucial challenges for every DSS development is identifying the specific 
requirements that the system must satisfy. For the CDSS this is even more important mainly 
due to medical-IT interdisciplinarity. In some cases, physicians are not aware that the medical 
context is not common knowledge. Similarly, engineers are unable to clearly understand the 
importance of some system parts necessary from physicians’ operational point of view. The 
solution is, therefore, having a suitable coordinator familiar with both fields, either a technician 
with a deeper knowledge of particular biological issue or a physician with a deeper knowledge 
of information systems. Identifying the specific requirements is the first task in the system 
analysis. The coordinator is actually a standard system analyst. Use of the title 'standard system 
analyst' is given by the job description as well as by the fact that generally main activity of the 
analyst should be mutual understanding of all considered in development. 
The uniqueness of the CDSS development is that it is not possible for a standard system analyst 
to learn in-depth all the necessary medical domain knowledge in a reasonable time. So, it is 
necessary to have medical professionals as a part of the analytical team throughout the analysis 
and development of the CDSS and to communicate with them. To summarize, the only possible 






In our case a biocybernetics expert was chosen as the system analysts. He had the required 
knowledge, in-depth knowledge of biology principles and considerable knowledge of IT. This 
expert with the medical domain knowledge was indispensable. When an IT expert, 
unacquainted with the medical background, receives a requirement (e.g., “the result must be 
HLA match”), he does not know what questions to ask and what specifically must be addressed 
to determine the exact requirement specification. Moreover, the added value of this choice was 
his knowledge of the system approach and applying the interdisciplinary principles in solving 
the IS design challenges. It was also preferable to have this person in the CDSS development 
management. 
 
Fig. 2. CDSS development life cycle 
The CDSS development life cycle is presented in Fig. 2. The analytical team consisted of 
medical professionals (future users – physicians and other health care professionals, e.g., other 
DCs, TCs, laboratory staff), the research team involved in the analysis, and a system analyst, 
who processed the system analysis and design of the CDSS. During performing this analysis he 
closely cooperated with medical professionals. A key decision was having a system analyst 
during the CDSS development for the medical-technical communication coordination. The 
development team implemented the designed system components, whose functionalities were 
verified by the system analyst and then validated by future users. Implementation of a system 
analyst increased the effectiveness of the development. IT professional could remain unaffected 
by the necessary medical knowledge issues. 
3.3 Challenge 3: System analysis, conceptual design of CDSS  
In order to handle the requirements of the users, to include prescriptive requirements of the 
supervisory organizations in the development of the IS and to change the processes and clinical 
operations of the CNMDR to a minimum degree, it was necessary to perform the system 
analysis as the first step. It meant to make an analysis of the existing system, which structure 
and functions were not obvious to users nor to the developers. The analysis was based on the 
sequential use of analytical techniques for data and process analysis, reverse engineering and 
database modeling and design tools.  
The goal of the process analysis was to monitor the activities and data interface (the data 
analysis is considered as a part of the process analysis) and it was generally a starting point for 
further optimization and reengineering. The mapping of the existing processes was carried out 
in cooperation with medical professionals and the system analyst on the basis of the CNMDR 
standard operational procedures. To perform this analysis, the interdisciplinary cooperation was 




crucial. Based on the analysis results, consequently specific requirements were more precisely 
specified and modified. 
The current CNMDR processes were recorded with the EPC methodology, the various activities 
listed in these diagrams were discussed in detail. The diagrams contained all activities of the 
whole process, i.e., the current activities supported by the ICT but also those unsupported, in 
the great majority solved manually. Within the CDSS, the conceptual design diagrams were 
then complemented by proposals of application support for these processes. In the third step, 
the processes were processed from the viewpoint of unified IS support and the required 
functionality including links to the designed data model were specified. 
According to the data and process analysis (especially inconsistencies of data sources and data 
duplicity in various sources) it was necessary to deal with the unification of the data base. For 
this reason, the "reverse engineering" of the existing system was performed. More specifically, 
a complete mapping of the current IS status quo was performed, which was focused on data 
sources in/outside IS, analysis of existing system modules, database structures and analysis of 
existing communication components. The analysis was performed using the computer-aided 
software engineering (CASE) tools. For existing applications particular system functions, the 
data flows between them and the data flows between functions and external interfaces (system 
inputs/output) have been documented. The functions were shown as diagrams in a hierarchical 
structure and described by short comments. Then, the diagrams of the ERM describing the 
structure of the database entities were processed. 
As a part of the CDSS conceptual design the data model of the IS was designed. A new unified 
database was proposed based on performed analysis and capturing new requirements and new 
functionality of the system (e.g., the components required for donor search according available 
DNA information). The IS database model was designed for the PostgreSQL database 
management system (originally database components used Firebird) and processed in the CASE 
tool Toad Data Modeler. The tool defines the database structure using the ER diagrams and all 
database functions required for the IS operation and allows generation of SQL/DDL scripts to 
create a functional PostgreSQL database. Considering the CNMDR as a public service 
organization, this solution was chosen due to the importance of using an open-source tool. Also 
smooth system extension was taken into account.  
According to the performed analysis results, the proposed data modification, and gained domain 
knowledge, the CDSS knowledge base was created. 
3.4 Challenge 4: Design of clinical decision support model and inference engine 
For the model-driven part of CDSS it was necessary to design a clinical decision support model 
and an inference engine ("search") and for the CDSS operation to invent an entirely new 
approach, both in terms of methodology and perspective of integration into the system. As the 
core of the system should use an advanced DNA-based donor search model, a lot of challenges 
were encountered during its development. Most of them were caused by working with medical 
data in the field of immunology, HLA issue specifically, and by having their own medical 
complexity depth (a very brief medical background of search process can be found in Section 
2). Description of each specific issue of challenge 4 is supplied with a brief description of the 
problem and its solution without going into unnecessary details. These issues are all given by 
specific clinical focus and by biocybernetics method used during research of the new search 
method. However, similar issues are addressed by the model-driven CDSS. 
Methodology 
Finding suitable stem cell donors comprises three independent processes: the donor pool HLA 
typing, the donor HLA haplotype inference, and the search for donor HLA phenotype matches. 
For practical and technical reasons, these processes are often decoupled leading to information 
losses along the way. So, this challenge was associated with a proposal of a method and 
methodology that would eliminate these losses.  
The designed common haplotype Expected-Maximization (chEM) method eliminates some of 





model and the inference engine utilization, it meant to propose the procedure for identification 
of probabilistic models of unrelated donors’ haplotypes with ambiguous typing, to propose a 
procedure for the required haplotype pairs identification and to obtain probabilistic models of 
patient-donor HLA phenotype matches at the required match level used in the search. This 
method is scalable in the number of HLA loci, the number of alleles (concrete specific gene 
variants), and typing ambiguity, overcoming the known curse of dimensionality for the problem 
of the HLA haplotype inference. A detailed description of the methodology can be found in [2]. 
HLA data and HLA typing level 
The complexity of data processing, identifying the haplotypes and the phenotypes required for 
the decision support is based on the use of the DNA techniques of HLA typing. The DNA locus 
may be identified specifically at the high typing level (specific allele) or at lower resolutions, 
e.g., in the form of multiple-allele codes (NMDP codes), which define the possible allele 
variants. Therefore, it was necessary to deal with this situation. Preprocessing such data was 
implemented directly in a PostgreSQL algorithm that decomposed the code into all possible 
variants of the specific alleles for the purpose of probabilistic models. These are then further 
used for patient-donor compatibility modeling. With the constantly increasing volume of 
specific alleles are the NMDP codes regularly updated on NMDP bioinformatics website [6] 
and it was necessary to handle a mechanism that allows the system to regularly update the list 
of those codes. 
However, the DNA typing techniques are relatively new, and the question arose of how to deal 
with historical HLA data that is obtained by outdated and inaccurate (especially for HLA-C 
genes) serological technique. For serological data it was necessary to find a conversion 
mechanism allowing uniform treatment of all data as DNA data. Correctness of serological data 
conversion was given by the use of serology-DNA conversion tables processed by an 
international team of medical experts, listed on the website [3]. Within the initial probabilistic 
models identification the conversion of the serological data of donors was performed. All new 
donors are typed by DNA techniques. 
Identification and verification of probabilistic models 
Some challenges were related to the identification of haplotype and phenotype probabilistic 
models and 5 loci haplotype pairs estimation. These were mainly related to the inability to 
identify haplotypes/haplotype pairs according to knowledge of existing haplotypes. That is why 
the identification process was partitioned into several steps. The first step concerned 
identification of the model over a defined set of donors. Then, in the cases of unidentified 
haplotype pairs special methods for rare haplotype identification were used, which perform the 
identification on the basis of B-C and HLA-DRB1-DQB1 genes linkage frequencies. The 
probabilistic model is then extended for a new rare haplotype or haplotype pair. The most 
common causes of impossibility of identifying donors’ haplotype/haplotype pairs while 
developing probabilistic models were serologically entered values of HLA-C locus (according 
to consultation with field experts 30% error rate) on one site, for donors with a high typing 
DNA level the occurrence of new or rare alleles on the other site. 
A function library for using haplotypes probabilistic model that allows key calculations needed 
to search was developed. The implemented functions are used primarily to calculate the 
frequency of alleles or haplotypes in the population, which is necessary for the analysis of 
genetic diversity, for the estimation of missing data (alleles), and for estimating the patient-
donor HLA compatibility, which is required for the actual search. For practical use it was 
necessary to periodically update this data (prior information autocompletion). For this reason a 
mechanism was integrated that triggers the model update daily at 2.00 a.m. The frequency of 
models updating must always be solved in accordance with time-consumption and clinical 
practice. 
An important challenge is models verification. In the case of the CDSS it is usually performed 
by a confrontation with expert knowledge of HLA experts and comparison with the results of 
the available knowledge of literature. These subjective methods were used, e.g., comparison of 




the outcomes of the previously performed searches according to physicians with the models 
predictions. An objective verification of probabilistic models was made by a verification typing 
of donors, i.e., HLA laboratory testing for determining the DNA alleles of all loci. The results 
of probabilistic models for the patient-donor match with the data from the knowledge base are 
necessary for the proper operation of the inference engine. Comparing the inference engine 
results with physicians’ results was an essential activity for the CDSS functionality verification.  
3.5 Challenge 5: System communication and data exchange security 
At this point it is convenient for better understanding to describe the donor selection 
communication path in a simplified form: the DC recruits a donor who is typed by the HLA 
laboratory and then recorded in the CNMDR; the TC or international registry requests for a 
donor search, the CC working with CNMDR database issues this search and the TC or 
international registry decides based on the search recommendation on selection of few potential 
donors for verification. The verification is carried out in cooperation with the DC and the HLA 
lab. After obtaining the results of verification, the TC chooses one particular donor.  
On the national level, the communication within the donor selection process was resolved by 
individual access of transplant process participants to a common database. The operating HW 
CNMDR server containing the PostgreSQL database is located and integrated into the 
University of West Bohemia standard ICT infrastructure equipped with the necessary 
technological background, such as backup power supplies, connection to backup systems, 
monitoring of operational status, permanent surveillance service etc. 
Because of the requirement of simple usability and readability of the CDSS results for users 
and the fastest possible information transfer between all new parts of the system as web 
applications (specifically for DCs, TCs and partially HLA lab) have been designed. The TC 
searching the donor has immediate access not only to the result of the search conducted by the 
CC, but also to the current status of donor verification carried out in cooperation with the DC 
and the HLA lab. The security policy and access to individual applications are based on the 
sensitivity of the data used and presented. On the operational HW server the access to the secure 
applications is limited (specific IP addresses + user name and password with a definition of the 
role of the user) and simultaneously the data transmission is encrypted via VPN (accessible via 
the relevant certificate on HW key protected by a PIN). 
On the international level, with worldwide registries the communication was automated 
connecting to European Marrow Donor Information System (EMDIS), the automatic email 
communication system. The above mentioned HW server containing the PostgreSQL database 
also contains the EMDIS server portion and the EMDIS mail server. The mail server itself 
allows individual restrictive setting of mail delivery only to selected and authorized clients 
(foreign registries), which increases security of communication system. The communication 
security is defined by the EMDIS standard and is processed by asymmetrical encryption of the 
messages in flexible message language format (FML messages) using PGP/OpenPGP. 
Due to the newly created system functions there was also a need to develop access to 
anonymised data that is used, e.g., for general data analysis or for publicly accessible 
visualization of WMDA key performance indicators. It is implemented as a database interface 
that accesses the auxiliary database, which is generated as an anonymised copy of the 
operational data. Due to the anonymised outputs the data cannot be directly linked to the donors 
or patients and thus they are freely available for general hypothesis testing or statistical 
calculations. 
4. Conclusion 
The objective of the paper was primarily to present various challenges of CDSS development, 
shown namely on CDSS for searching and selecting a suitable donor for bone marrow 
transplantation, as the methodological guidelines for researchers in the field where hybrid DSS 
is needed, IS development is driven by permanently changing user requirements, and 





in clinical practice. The described CDSS was deployed in 2014 and it is used in clinical practice. 
In 2015, the search algorithm and IT system solution and its correctness were certificated as a 
part of CNMDR accreditation by international accreditation organization WMDA. 
So, what can be considered as critical points and challenges of the CDSS development? Is it 
assessment of users requirements, CDSS development management, interdisciplinary 
cooperation among professionals, establishing the use of the CDSS, utilization of the CDSS 
applications and communication components, changes in methodologies for the health care 
organization, knowledge and model base correctness, decision support accuracy?  
Each point can be critical, none of them can be neglected, and all must be coordinated with 
each other throughout the whole development process. Neglecting any of them could have fatal 
consequences for the entire project. The key is a common feedback from medical professionals 
to IT professionals and vice versa, to prevent misunderstanding. A communication link must 
be well-timed, i.e., development requires the involvement of medical professionals in the 
analytical team. Equally, the role of a coordinator with the deep domain knowledge and his 
communication with IT is crucial. In the case of the CDSS it is very difficult for a standard 
system analyst to gain this knowledge. For successful CDSS development, mainly for reasons 
of efficiency, it is important to use agile methodologies. Agility by itself does not solve the lack 
of knowledge but a coordinator knowledgeable in those methodologies and the medical domain 
can streamline the development process of CDSS. 
New methods and the necessary decision-making models required for model-driven part of the 
CDSS are not often developed by medical professionals but by analytical professionals. 
Involvement of physicians within the validation of these methods and models is necessary. 
However, the willingness of medical professionals to make changes in operations and operating 
procedures with regard to the involvement of IS to these procedures plays also a significant 
role. It can therefore be concluded that the basis for a successful CDSS development is given 
by medical-(researcher)-IT communication and its well-built management. 
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